This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
News|Articles|September 4, 2009
Walgreens releases specialty pharmacy report
Author(s)Alaina Scott, Senior Editor
Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report. Keep reading to find out more.
Advertisement
Walgreens recently announced the release of its Specialty Pharmacy State of the Industry report, which offers a snapshot of the specialty pharmacy market's evolving trends, as well as solutions for managing costs and improving care.
The report is available online at
Advertisement
Related to this article
Eli Lilly’s new indication helps improve medication delivery for adults with type 2 diabetes, reducing annual injections by over 300.
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
The approval is the first new treatment advance in more than 30 years for chronic kidney disease for adults with type 1 diabetes.
Pharmacist and public health expert Jennifer Hammons, PharmD, DrPH, discusses pharmacy as essential infrastructure amid rural pharmacies persistently being overlooked.
An American Heart Association scientific statement shows earlier risk factors and social barriers driving cardiovascular disparities in Hispanic adults.
In an exploration of 2 distinct timeframes in the 21st century, researchers examine the use and concurrent use of medication types among elderly US adults.
Advertisement
Advertisement
Trending on Drug Topics
1
Muscle Preservation Is Key in GLP-1 Therapy for Postmenopausal Women
2
Early CGMs Results in Better 5-Year Glucose Control in Type 1 Diabetes
3
Polypharmacy, Drug Interactions Threaten Older Adults’ Medication Safety
4
Tozorakimab Reduces COPD Exacerbations in Phase 3 Trials
5